Does PAZOPANIB Cause Activated partial thromboplastin time prolonged? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Activated partial thromboplastin time prolonged have been filed in association with PAZOPANIB (Pazopanib). This represents 0.0% of all adverse event reports for PAZOPANIB.
5
Reports of Activated partial thromboplastin time prolonged with PAZOPANIB
0.0%
of all PAZOPANIB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Activated partial thromboplastin time prolonged From PAZOPANIB?
Of the 5 reports, 4 (80.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Activated partial thromboplastin time prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PAZOPANIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does PAZOPANIB Cause?
Death (3,767)
Diarrhoea (2,907)
Fatigue (1,883)
Nausea (1,879)
Malignant neoplasm progression (1,471)
Drug ineffective (1,135)
Decreased appetite (1,116)
Vomiting (1,072)
Hypertension (1,004)
Malaise (764)
What Other Drugs Cause Activated partial thromboplastin time prolonged?
DABIGATRAN ETEXILATE (264)
HEPARIN (225)
RIVAROXABAN (163)
WARFARIN (146)
ACETAMINOPHEN (119)
ALLOPURINOL (110)
AMIODARONE (99)
METRONIDAZOLE (98)
SIMVASTATIN (94)
DARBEPOETIN ALFA (93)
Which PAZOPANIB Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?
PAZOPANIB vs PEANUT
PAZOPANIB vs PEG INTERFERON
PAZOPANIB vs PEG-INTERFERON ALFA 2A
PAZOPANIB vs PEGASPARGASE
PAZOPANIB vs PEGASYS